echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > COVID vaccines may reduce mortality in low- and middle-income countries

    COVID vaccines may reduce mortality in low- and middle-income countries

    • Last Update: 2022-11-26
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
      |           

    A health worker vaccinates a man against COVID-19 in India
    .

    According to a mathematical model1 that combines data from 152 countries, more than 1 million lives
    could be saved if COVID-19 vaccines were shared more equitably with low-income countries in 2021.

    The impact of vaccine sharing will be greater
    if, while more vaccines are distributed to poorer countries, other mitigation measures, such as limiting gatherings and wearing masks, are implemented for longer.
    Models show that up to 3.
    8 million lives could be saved
    in this scenario.

    It is widely believed that unfair vaccine distribution leads to unnecessary loss
    of life.
    But Oliver Watson, an infectious disease epidemiologist at Imperial College London, says estimating the scale of this loss can help us plan
    for future epidemics.
    "This is another piece of evidence of how big an impact
    the push for vaccine coverage could have," he said.
    This is important
    for galvanizing political will and making major political decisions.

    Obvious gaps

    By the end of last year, nearly half of the world's population had received two doses of COVID-19 vaccine
    .
    But these vaccines are not distributed equitably: 75% in high-income countries, but less than 2%
    in some low-income countries.
    Rich countries ended the year with vaccine surpluses and plan to vaccinate
    young children at relatively low risk of severe disease.
    At the same time, many poorer countries still do not have enough vaccine supplies to vaccinate
    those most at risk of dying from COVID-19.

    Sam Moore, a mathematical epidemiologist at the University of Warwick in Coventry, UK, and his colleagues used data on over-mortality and vaccine availability to simulate what would happen
    if vaccines were distributed based on demand rather than wealth.
    They considered the impact of
    vaccination on SARS-CoV-2 transmission and COVID-19 severity.

    The team found that fairer vaccine coverage could have averted 1.
    3 million deaths globally had it been had other policies to reduce physical contact (see "The brutal cost of vaccine inequality").

    If high-income countries had insisted on other measures to reduce transmission, more than twice as many deaths
    could have been avoided.
    The findings were published October 27 in
    the journal Nature Medicine.

    The study only looked at vaccine availability and did not take into account other factors such as storage and vaccination capacity
    .

    This result fits well with a previous study by Watson and colleagues, which used similar modeling techniques but with different data
    .
    The study found that about 45% of COVID-19 deaths in low-income countries could be avoided if they met the 20% vaccination coverage target set by COVAX2 by the end of 2021
    .

    Moore said a fairer sharing of vaccines and the resulting decline in infection rates may also have slowed the emergence
    of new SARS-CoV-2 variants.

    Policymakers can refer to such research to lay the groundwork for a better response to the
    next pandemic.
    Moore said that while it may be unrealistic to expect countries to distribute vaccine supplies before they vaccinate their citizens, governments may be able to find a middle ground
    .
    "First world countries should vaccinate all people over the age of 60 to protect the most vulnerable before
    helping other countries catch up," he said.
    Even if it's not fair, once you manage to get your own vaccine to some extent, maybe there's some kind of room to
    help other countries.

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.